Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program. The alliance ...

Whiskey brand, owned by Japanese drinks group Suntory, to close main distillery amid tariff uncertainty The maker of Jim Beam bourbon whiskey will halt production at its main site in Kentucky for all ...